OUTCOME OF BOARD MEETING
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd held a board meeting on 2 September 2025 at its registered office in Indore (11:00 AM to 4:15 PM). The Board approved its Annual Report and fixed the date and notice for the 32nd Annual General Meeting, along with book closure dates and the cut-off date for remote e-voting. It approved the re-appointment of Mr. Sanjay Sethi (DIN: 00090277) as Managing Director for a further term of five years, subject to shareholder approval at the upcoming AGM. It also appointed Dipika Ketaria as the Secretarial Auditor for a five-year term (2025–2030) and as Scrutinizer for the AGM e-voting process, both subject to shareholder approval.
These are largely procedural AGM-related decisions and do not directly affect earnings; however, the 5-year re-appointment of the existing MD signals leadership continuity for shareholders, while the appointment of a new Secretarial Auditor is part of routine governance compliance.